-
Founded in:
1991-12-15 -
Country:
China -
Address:
No. 27 Xinyang Avenue, Fuyang Economic and Technological Development Zone -
Tax NO.:
913412007349648451 -
Registered Funds:
16.8 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Berberine hydrochloride |
Effective for intestinal infections caused by Shigella dysenteriae and Escherichia coli
More
Effective for intestinal infections caused by Shigella dysenteriae and Escherichia coli |
0.1g | 633-65-8 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ibuprofen |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
15687-27-1 | 53 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hawthorn |
|
0 | ||
| Malt (roasted) |
|
0 | ||
| Liu Shenqu (fried with bran) |
|
0 | ||
| Sucrose |
|
57-50-1 | 72 | |
| Citric acid monohydrate |
|
5949-29-1 | 39 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nifedipine |
By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.
More
By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced. |
21829-25-4 | 75 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sineptina |
This product is a macrolide antibiotic with the same mechanism of action as erythromycin and a similar antibacterial spectrum as erythromycin. Its antibacterial activity against most Gram-positive bacteria is slightly poorer, and some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, Bordetella pertussis, Rickettsia and Chlamydia trachomatis.
More
This product is a macrolide antibiotic with the same mechanism of action as erythromycin and a similar antibacterial spectrum as erythromycin. Its antibacterial activity against most Gram-positive bacteria is slightly poorer, and some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, Bordetella pertussis, Rickettsia and Chlamydia trachomatis. |
1392-21-8 | 8 |